Companies / Revolution Medicines, Inc.
Revolution Medicines, Inc.
Financials · FY2025
Ownership
214.3M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.39% | 2,975,203 |
| Institutions | 94.87% | 203,346,235 |
| Public float | 3.74% | 8,014,980 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Borisy AlexisDirector | 1.09% | 2,340,075 |
Goldsmith Mark aSee Remarks · Director | 0.15% | 331,754 |
Kelsey Stephen MichaelFormerSee Remarks | 0.14% | 295,398 |
Horn Margaret AChief Operating Officer | 0.07% | 154,647 |
Anders JackChief Financial Officer | 0.06% | 125,512 |
Wang XiaolinFormerSee Remarks | 0.05% | 116,063 |
Wei LinFormerChief Medical Officer | 0.05% | 101,366 |
Cislini JeffFormerGeneral Counsel | 0.03% | 58,518 |
Mancini AnthonyFormerSee Remarks | 0.03% | 54,400 |
Anderson Elizabeth MDirector | 0.01% | 23,215 |
Institutional holders 421
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.56B | 6.39% | |
| $1.33B | 7.80% | |
| $1.16B | 6.80% | |
| $949.54M | 4.56% | |
| $929.26M | 4.46% | |
| $917.12M | 2.28% | |
| $684.03M | 4.01% | |
| $605.43M | 3.55% | |
| $556.57M | 3.26% | |
| $551.84M | 1.37% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | — | $893.16M | +4.8M +53.43% | 13,695,790 6.39% of shares | high |
| Q3 2025 as of | Farallon Capital Management LLC 13F manager | New | — | $683.02M | +14.6M | 14,625,692 6.82% of shares | high |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Add | — | $318.01M | +3.3M +148.26% | 5,475,611 2.55% of shares | high |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Trim | — | $-246.66M | -2.5M -20.62% | 9,766,496 4.56% of shares | high |
| Q1 2026 as of | General Atlantic, L.P. 13F manager | Trim | — | $-204.72M | -2.1M -74.84% | 707,791 0.33% of shares | high |
| Q1 2026 as of | Norges Bank 13F manager | Exit | — | $-195.57M | -2.5M -100.00% | — | high |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Add | — | $160.27M | +856K +2656.37% | 888,019 0.41% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $147.53M | +788K +19.17% | 4,897,051 2.28% of shares | high |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Farallon Capital Partners, L.P. | Passive13G/A | — |
| Baker Bros. Advisors LP | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| RVMD | — | 76155X100 |